Biotekniikan ennakointi -projektin tavoitteena on ollut selvittää bioteknologian muuntumista kaupalliseksi tuotannoksi sekä esittää sen pohjalta suosituksia kehittää koulutusjärjestelmää kaupallisen tuotannon edistämiseksi vuoteen 2020 asti. Liiketoimintaosaamisen pikaiseksi...

The aim of this study is to depict the ownership and financial structure of Finnish small and medium-sized biotechnology enterprises. Most of the firms are owned by several groups of owners. In small companies the largest share of equity is held by individuals active in the business. Private...

New technological applications are usually expected to increase the health care costs. But they can also spawn cost savings in the long run, for example, when making time-consuming diagnostic methods more efficient and facilitating targeted therapy. This study analyses how the implementation of...

Tässä tutkimuksessa simuloidaan lääkekehitykseen suuntautuneiden pienten ja keskisuurten biotekniikkayritysten tulevaisuutta, erityispainopisteenä kansantaloudelliset implikaatiot. Simulaatiossa huomioidaan vaihtoehtoisia kehityspolkuja, joiden avulla on arvioitu erilaisten...

The need for the strategic initiatives for biotechnology strategy emerged in interviews with 90 Finnish biotechnology leaders in the ETLA Biotechnology Survey, conducted at the end of 2004. This paper discusses on the policy implications for the project on “The biotechnology industry as a part...

ETLA, the Research Institute of the Finnish Economy, conducted surveys at the end of 2004 and at the beginning of 2002 on the enterprises listed in the Index of Biotechnology Companies in the Finnish Bioindustries organization. The surveys provide data on financial accounting, R&D activities,...

Patents form a central pathway for capturing the value of intangible assets in a knowledge-intensive business. Patents can potentially generate and support earnings in two ways: they can be traded or licensed out, and they can provide critical protection for core production technologies or...

In this paper our aim is to assess the evolution of the Finnish biotechnology sector during the 2000's. Particular focus is given to the growth expectations and realized outcomes of Finnish biotechnology companies, to the evolution of public investments, and to potential determinants of company...

The turnover of the companies in North Savo in 2011 was nearly 10 billion euros, of which industry accounted for just under a third. The industrial structure of the region is not strong, but on the other hand it is not alarmingly thin either, because it does have certain successful niches. North...

This paper utilizes queuing models to analyze health care processes. We extend previous queuing models to allow for i) heterogeneous resources, ii) resource allocation to various tasks, and iii) teams (complementary resources). We model a process of one clinical unit. We use the model to analyze...